RPT for half year ended September 30, 2023

Intimation for launch of Paclitaxel in Canada

USFDA Inspection of Panacea Biotec Pharma Ltd facility at Baddi

Disclosure for commencement of Arbitration Proceeding by Apotex

Intimation of Closure of Trading Window

Reclassification from Promoter's Group Category to Public Category

Change in Senior Management of Material Subsidiary Company

Intimation of Closure of Trading Window w.e.f. July 01, 2023

Disclosure for Launch of Food & Nutritional Products by PBPL

Related Party Transactions for half year ended March 31, 2023